Insider · CIK 0001485508
Cooper C. Collins
Files at TXMD (TherapeuticsMD, Inc.). First filing -, latest -.
Cooper C. Collins files SEC Form 4 as director at TXMD (TherapeuticsMD, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Cooper C. Collins has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | TXMD TherapeuticsMD, Inc. | AGrant or award Restricted Stock Unitsderivative | +8,500 | $0.00 | $0 | 8,500 | Nov 5, 2025 |
| Feb 18, 2025 | TXMD TherapeuticsMD, Inc. | MOption exercise Common Stock | +8,500 | $0.00 | $0 | 60,516 | Feb 20, 2025 |
| Feb 18, 2025 | TXMD TherapeuticsMD, Inc. | MOption exercise Restricted Stock Unitsderivative | -8,500 | $0.00 | $0 | 0 | Feb 20, 2025 |
Questions about Cooper C. Collins
Answered from the filings on this page, as of the latest one.
Is Cooper C. Collins buying or selling?
Cooper C. Collins has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Cooper C. Collins's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cooper C. Collins has 0.
Where does Cooper C. Collins file Form 4?
Cooper C. Collins has filed Form 4 at TXMD (TherapeuticsMD, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.